September 18, 2026

Starlink’s telecoms expansion could reshape network economics

Starlink’s expansion into a hybrid telecoms model highlights growing network complexity and the need for flexible telecoms software platforms...

Ruffer targets the next beneficiaries of AI spending

Ruffer is targeting consumer, industrial and financial companies that could benefit as wealth created by AI investment spreads through the wider economy...

Meridian Holdings Delivers 16% Revenue Growth as Customer Registrations Reach Record Levels, Zacks Small-Cap Research

Meridian Holdings reports 16% second-quarter revenue growth as record registrations support expanding customer activity and improved profitability...

VADO targets demand for space-saving bathroom solutions

VADO is targeting smaller bathrooms with a range of space-saving furniture, shower storage, WC units and accessories...

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem with 55.71% Potential Upside

Kamada Ltd. (NASDAQ: KMDA), an Israel-based healthcare company specializing in plasma-derived protein therapeutics, is garnering attention from investors due to its robust revenue growth and promising..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Clinical-Stage Biotech with a 49.90% Upside Potential

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biotechnology firm headquartered in Boston, Massachusetts, is gaining traction among investors due to its promising pipeline and significant potential upside...

AngioDynamics, Inc. (ANGO) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings

AngioDynamics, Inc. (NASDAQ: ANGO) is garnering attention among healthcare investors as it stands poised for potential growth, driven by strategic advancements in medical technology. With a..

Prothena Corporation plc (PRTA) Stock Analysis: Unveiling a 153% Upside Potential Amidst Biotech Challenges

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology firm headquartered in Dublin, Ireland, is capturing the attention of investors with an impressive potential upside of 152.96%. Specializing..

Celcuity Inc. (CELC) Stock Analysis: Unpacking an 89.32% Potential Upside in Biotech

Investors looking for high potential in the biotechnology sector should take note of Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotech company with a strong focus on..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 58.6% Potential Upside Beckons Biotech Investors

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is capturing the attention of savvy investors in the biotechnology sector with its groundbreaking work in monoclonal antibody therapeutics. As a..

Oric Pharmaceuticals (ORIC) Stock Analysis: A 60% Upside Potential with Strong Buy Ratings in Biotech

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing investor attention with its promising potential for substantial upside. As a clinical-stage biopharmaceutical firm, Oric focuses on developing innovative..

Abivax SA (ABVX) Stock Analysis: Exploring a 54% Potential Upside in the Biotech Sector

Abivax SA (ABVX), a clinical-stage biotechnology company headquartered in Paris, France, is capturing the attention of investors with a substantial potential upside of 54.22%. Specializing in..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 50% Upside Potential

Orthofix Medical Inc. (NASDAQ: OFIX) is positioning itself as a compelling opportunity within the healthcare sector, specifically in the medical devices industry. With a market capitalization..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling a 98% Upside Potential Despite Current Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services sector, presents a captivating case for investors willing to delve into a company..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Tapping into a 24.82% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is making waves in the healthcare sector, especially within the niche of specialty and generic drug manufacturing. With a market capitalization..

COMPASS Pathways Plc (CMPS) Stock Analysis: Strong Buy Ratings and 58% Upside Potential

COMPASS Pathways Plc (CMPS) is making waves in the healthcare sector with its innovative approach to mental health treatment. As a biotechnology company headquartered in London,..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 486% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Upstream Bio, Inc. (NASDAQ: UPB) an intriguing prospect, especially given its substantial potential upside of 486.49%...

Humacyte, Inc. (HUMA) Stock Analysis: Unpacking a 221.68% Potential Upside in the Biotech Arena

Investors navigating the volatile waters of the biotechnology sector may want to give Humacyte, Inc. (NASDAQ: HUMA) a closer look. With a promising potential upside of..

Standard BioTools Inc. (LAB) Stock Analysis: Potential Upside with a Target Price of $1.35

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector with a focus on medical devices, is drawing attention from investors with a noteworthy potential..

Search

Funds

September 18, 2026

Starlink’s telecoms expansion could reshape network economics

Starlink’s expansion into a hybrid telecoms model highlights growing network complexity and the need for flexible telecoms software platforms...

Ruffer targets the next beneficiaries of AI spending

Ruffer is targeting consumer, industrial and financial companies that could benefit as wealth created by AI investment spreads through the wider economy...

Meridian Holdings Delivers 16% Revenue Growth as Customer Registrations Reach Record Levels, Zacks Small-Cap Research

Meridian Holdings reports 16% second-quarter revenue growth as record registrations support expanding customer activity and improved profitability...

VADO targets demand for space-saving bathroom solutions

VADO is targeting smaller bathrooms with a range of space-saving furniture, shower storage, WC units and accessories...
Search

Funds

September 18, 2026

FTSE 100

Funds